Life Sciences & Healthcare  Newsletters

Kempen European Life Sciences ECM update 

  • Monthly update on Equity Capital Markets of European Life Sciences companies
  • Provides insights on market developments, financing transactions, share price developments and other relevant insights in the field of ECM
  • Example analysis from the January 2018 ECM update below

2017 sub-sector performance of European small- and midcap Life Sciences companies

  • In a generally strong year for European Life Sciences, Biotech strongly outperformed other Life Sciences subsectors in 2017, closing the year at +42.5%.
  • Contrary to 2016 in which they ranked first, Generics companies underperformed by increasing only 14.3% over the past year.

Source: Bloomberg
Note: Based on Kempen Life Sciences index (Biotech (40), CRO/CMO (6), Diagnostics (11),
Generics (8), Medtech (42), Specialty Pharma (41), Other (14; not included))

Kempen European Life Sciences M&A update 

  • Bi-monthly update on Mergers & Acquisitions of European Life Sciences companies
  • Provides insights on the current M&A climate, recent developments, transactions and other relevant insights in the field of M&A 
  • Example analysis from the November 2017 M&A update below

Red hot European Life Sciences M&A market in 2017

Red Hot European Life Sciences in 2017  

  • In total, 140 European linked* Life Sciences transactions were announced in 2017
  • North America based companies were the most active acquirers, with 30 announced transactions; in Europe, UK companies were the most active acquirers with 20 announced transactions
  • Canada and US based companies were also the most targeted companies, with 39 announced transactions by a European acquirer
  • In the Benelux, the UK and Asia, many more companies were acquirer than target; in Germany, North America and Spain and Portugal more companies were targets than acquirers

* i.e. transactions involving a European target, a European acquirer, or both

Subscribe now

Leave your company email address here to receive our Life Sciences & Healthcare Newsletters